The FDA has granted 501 (k) clearance to the EXENT® System, a fully automated device for assessing monoclonal gammopathies, ...
Exact Sciences Corp ((EXAS)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...
Hosted on MSN
Copilot Meets Python in Excel — First Hands-On Test
If you use Excel 40 hours a week (and those are the weeks you are on vacation), welcome to the MrExcel channel. Home to 2,400 free Excel tutorials. Bill "MrExcel" Jelen is the author of 67 books about ...
Thermo Fisher Scientific has launched a new diagnostic test to help physicians better detect and manage lung transplant rejection. Dubbed the Molecular Microscope Diagnostic System for Lung, the test ...
Florida State might look like an underdog now, but they were once explosive under Jimbo Fisher. After taking over for legendary Bobby Bowden, Fisher immediately showed what he’s capable of by winning ...
A world-renowned pianist will take the stage on Adelphi University’s campus on Sunday, Oct. 5. Philip Edward Fisher will play at the Westermann Stage in the Adelphi University Performing Arts Center, ...
Using a new skin care product without testing it first can potentially cause allergic contact dermatitis, an inflammatory skin condition in which the immune system overreacts to an ingredient in the ...
Exact Sciences has launched its long-awaited blood test designed to detect the early stages of multiple tumors, with a plan to sell it to consumers through a telehealth program in a bid to increase ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
(RTTNews) - Exact Sciences Corp. (EXAS) announced the U.S. launch of Cancerguard™, its multi-cancer early detection or MCED blood test, now available as a laboratory-developed test or LDT. Cancerguard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results